immunosuppressivum
Monoclonal IgG
Selective adhesion molecule inhibitor
|
|
|
Crizanlizumab (substance)
Crizanlizumab
Id
830160007
Status
Primitive
Has disposition
immunomodulator
Has disposition
selectieve adhesiemolecuulremmer